Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massar

Showing results (271-280 of 300) with videos related to

Pageof 30
Sort By:
ESC Heart Failure|February 19, 2026
Effects of Empagliflozin on Right Ventricular Free-Wall Strain in Patients with Heart Failure and Reduced Ejection FractionMassar Omar, Jesper Jensen, Mulham Ali, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection FractionMassar Omar, Jesper Jensen, Peter H Frederiksen, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 12, 2000
Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trialS Guandalini, L Pensabene, M A Zikri, et al.
American Heart Journal|March 9, 2026
Empagliflozin and Functional Aerobic Capacity in Individuals with Increased Risk of Heart Failure: The Empire Prevent Cardiac TrialJulie H Larsen, Camilla F Andersen, Mathilde Mb Jessen, et al.
Journal of Cardiac Failure|March 14, 2026
The effect of empagliflozin on left ventricular mass and volumes in elderly individuals with overweight and high risk of heart failure: The Empire Prevent Cardiac TrialJulie Hempel Larsen, Camilla Fuchs Andersen, Maria Callesen Hansen, et al.
American Journal of Human Genetics|February 19, 2025
Single-cell transcriptomics reveals inter-ethnic variation in immune response to Falciparum malariaTala Shahin, Jakub Jurkovic, Mame Massar Dieng, et al.
European Journal of Preventive Cardiology|January 8, 2026
Effects of empagliflozin in patients at risk of heart failure: the Empire Prevent Metabolic TrialCamilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
American Heart Journal|May 5, 2022
The effect of empagliflozin on contractile reserve in heart failure: Prespecified sub-study of a randomized, double-blind, and placebo-controlled trialJesper Jensen, Massar Omar, Mulham Ali, et al.
Cardiovascular Diabetology|June 13, 2026
The effect of empagliflozin on inflammation in patients with overweight or obesity and risk of heart failure: a substudy from the Empire Prevent Metabolic trialCamilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
The Lancet. Diabetes & Endocrinology|December 28, 2020
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
Pageof 30

Showing results (271-280 of 300) with videos related to

Sort By:
Pageof 30
ESC Heart Failure|February 19, 2026
Effects of Empagliflozin on Right Ventricular Free-Wall Strain in Patients with Heart Failure and Reduced Ejection FractionMassar Omar, Jesper Jensen, Mulham Ali, et al.
Medrxiv : the Preprint Server for Health Sciences|June 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection FractionMassar Omar, Jesper Jensen, Peter H Frederiksen, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 12, 2000
Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trialS Guandalini, L Pensabene, M A Zikri, et al.
American Heart Journal|March 9, 2026
Empagliflozin and Functional Aerobic Capacity in Individuals with Increased Risk of Heart Failure: The Empire Prevent Cardiac TrialJulie H Larsen, Camilla F Andersen, Mathilde Mb Jessen, et al.
Journal of Cardiac Failure|March 14, 2026
The effect of empagliflozin on left ventricular mass and volumes in elderly individuals with overweight and high risk of heart failure: The Empire Prevent Cardiac TrialJulie Hempel Larsen, Camilla Fuchs Andersen, Maria Callesen Hansen, et al.
American Journal of Human Genetics|February 19, 2025
Single-cell transcriptomics reveals inter-ethnic variation in immune response to Falciparum malariaTala Shahin, Jakub Jurkovic, Mame Massar Dieng, et al.
European Journal of Preventive Cardiology|January 8, 2026
Effects of empagliflozin in patients at risk of heart failure: the Empire Prevent Metabolic TrialCamilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
American Heart Journal|May 5, 2022
The effect of empagliflozin on contractile reserve in heart failure: Prespecified sub-study of a randomized, double-blind, and placebo-controlled trialJesper Jensen, Massar Omar, Mulham Ali, et al.
Cardiovascular Diabetology|June 13, 2026
The effect of empagliflozin on inflammation in patients with overweight or obesity and risk of heart failure: a substudy from the Empire Prevent Metabolic trialCamilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
The Lancet. Diabetes & Endocrinology|December 28, 2020
Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trialJesper Jensen, Massar Omar, Caroline Kistorp, et al.
Pageof 30